Philips Respironics Trilogy EV300, Software Version 1.05.15.00. Continuous home-use ventilator device.
Published April 1, 2026 · Recall initiated: March 2, 2026
Summary
FDA records medical device Class I recall Z-1616-2026, published April 1, 2026 and initiated March 2, 2026. Recalling firm: Philips Respironics, Inc.; Status: Ongoing; Reported quantity: 113,717 units; Lot: All Model No.; All UDI; All Serial No. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Using non-pneumatic nebulizers with Trilogy Evo Platform ventilators may result in a discrepancy between the set tidal volume and the tidal volume received by the patient.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Philips Respironics, Inc.
- Distributor
- Worldwide distribution: US (Nationwide) and OUS (Foreign) to countries of: Argentina, Austria, Australia, Bosnia and Herzegovina, Bangladesh, Belgium, Bulgaria, Bolivia, Brazil, Bahamas, Canada, Switzerland, Chile, China, Colombia, Czech Republic, Germany, Denmark, Algeria, Ecuador, Estonia, Egypt, Spain, Finland, France, Georgia, French Guiana, Gibraltar, Greece, Guatemala, Hong Kong, Croatia, Hungary, Indonesia, Ireland, Israel, India, Italy, Jersey, Jordan, Japan, Kenya, South Korea, Kuwait, Lebanon, Lithuania, Morocco, Montenegro, North Macedonia, Myanmar, Martinique, Malta, Mexico, Malaysia, Nigeria, Netherlands, Norway, Nepal, New Zealand, Oman, Panama, Peru, French Polynesia, Philippines, Pakistan, Poland, Portugal, Paraguay, Qatar, R®union, Romania, Serbia, Russia, Saudi Arabia, Sweden, Singapore, Slovenia, Slovakia, Thailand, Tunisia, Turkey, Taiwan, Ukraine, United Arab Emirates, United Kingdom, Vietnam, Mayotte, South Africa, Zimbabwe.
- Lot
- All Model No.; All UDI; All Serial No.
- Risk classification
- Class I
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAPhilips Respironics Trilogy Evo Universal, Software Version 1.05.15.00. Continuous home-use ventilator device.April 1, 2026
- FDAHCS - Headless Compression Screw System, Headless Compression Screw, Cannulated; Article Numbers: 31207-10,April 1, 2026
- FDAFLS - Foot Locking Plates System and HOL - Hallux Osteotomy Locking Plate with the below descriptions andApril 1, 2026
- FDABiPAP A40 Ventilator. Used to provide noninvasive ventilation support for the purpose of treating adult andJuly 9, 2025
- FDAGarbin Evo. Model Number: LD2110X23B. Intended for invasive and non-invasive ventilation of pediatric throughNovember 20, 2024
- FDATrilogy EV300. Model Numbers: DS2200X11B, IN2200X15B, BL2200X15B, BR2200X18B, CA2200X12B, DE2200X13B,November 20, 2024
Questions about this recall
Was Philips Respironics Trilogy EV300, Software Version 1.05.15.00. Continuous home-use ventilator device. recalled?
Yes. FDA published recall Z-1616-2026 on April 1, 2026. Reported hazard: Using non-pneumatic nebulizers with Trilogy Evo Platform ventilators may result in a discrepancy between the set tidal volume and the tidal volume received by the patient.
What should I do if I have this product?
Voluntary: Firm initiated · Letter